excuse my simplicity
but they sold 4000 units last quarter - one would expect more since they now have reimbursement and official launch - and lets forget for now 40% growth 1/4 on 1/4
but lets stick with 4000 units @ US $4000 (might even be $5k) a pop times 4 quarters for the year
min US$64m rev. 70% gross margin = $45 m
id actually expect double that figure but dont that put in a a forward P/E of around 20 times ? double is 10 times (back of envelope figures)
throw in a second generation product and potential therapy use a year from now on prostate alone .. then peg in the other organs ?
Novartis more interested in therapy than imaging. Lacametz not approved for cyclotron . Lantheus locked out of use for patient selection (TLX label extension forthcoming)
... seems like value but wotdoino
- Forums
- ASX - By Stock
- TLX
- Is a $2,131,889,198.56 market cap justified
Is a $2,131,889,198.56 market cap justified, page-32
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.96 |
Change
0.960(4.57%) |
Mkt cap ! $7.349B |
Open | High | Low | Value | Volume |
$21.50 | $21.97 | $21.08 | $22.91M | 1.059M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $21.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.96 | 205 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 456 | 21.860 |
1 | 170 | 21.800 |
1 | 300 | 21.650 |
2 | 285 | 21.600 |
1 | 33 | 21.530 |
Price($) | Vol. | No. |
---|---|---|
21.960 | 205 | 1 |
22.000 | 2505 | 5 |
22.040 | 426 | 1 |
22.050 | 3000 | 1 |
22.060 | 1000 | 1 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |